CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- 4 Open-market sale See Remarks sold 3,026 shares at $20.40 ($61,715)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market sale Director sold 274,000 shares at $28.43 ($7,790,943)
- 4 Gift Director gave 172,840 shares (gift)
- 4 Open-market sale See Remarks sold 1,079 shares at $23.35 ($25,195)
- 4 Open-market sale CEO sold 9,790 shares at $23.35 ($228,597)
- 4 Open-market sale General Counsel sold 1,048 shares at $23.35 ($24,471)
- 4 Open-market sale See Remarks sold 4,046 shares at $23.35 ($94,474)
- 4 Open-market sale See Remarks sold 833 shares at $22.87 ($19,051)
- 4 Open-market sale Director sold 80,000 shares at an average $24.32 ($1,945,785)
- 4 Open-market sale See Remarks sold 12,532 shares at $24.64 ($308,763)
- 3 Insider Initial Statement of Ownership
Page 7 of 21 · 406 filings